Skip to main content

Table 2 CHEERS Checklist

From: Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review

Items/studies

Title

Abstract

Background and objectives

Target population and subgroups

Setting and location

Study perspective

Comparators

Time horizon

Discount rate

Choice of health outcomes

Measurement of effectiveness

Gil-Rojas [24]

Liao [20]

Yao [23]

Mc Ewan [18]

Isaza [21]

Parizo [17]

Savira [22]

Mendoza [19]

Krittayaphong [25]

Jiang [16]

Items/studies

Measurement and valuation of preference based outcomes

Estimating resources and costs

Currency, price date, and conversion

Choice of model

Assumptions

Analytical methods

Study parameters

Incremental costs and outcomes

Characterizing uncertainty

Characterizing heterogeneity

Study findings, limitations, generalizability, and current knowledge

Source of funding

Conflict of interests

Total

Gil-Rojas [24]

23.0

Liao [20]

24.0

Yao [23]

23.5

Mc Ewan [18]

22.5

Isaza [21]

21.5

Parizo [17]

24.0

Savira [22]

24.0

Mendoza [19]

22.0

Krittayaphong [25]

22.0

Jiang [16]

20.5